Hence, ANGPTL4 represents a potential therapeutic target in the treatment of prostate cancer, it may be possible to disrupt tumor growth and survival mechanisms, offering a novel approach for the treatment of prostate cancer. This evidence concerns the gene ANGPTL4 and Familial prostate cancer.